Intended for healthcare professionals

How I approach primary hyperhidrosis management

An article on managing localised hyperhidrosis appeared in these pages three years ago. In it, Kleyn and Hepburn reviewed the problem of excessive sweating and several ways of treating it. Subsequently, botulinum toxin A – Botox® (Allergan Ltd, UK) – has represented a breakthrough in the treatment of hyperhidrosis. Since its advent I have seen a marked increase in the number of referrals for the management of this problem. I offer here an account of my approach to hyperhidrosis, with updated information on its prevalence and information on how to obtain some useful pharmacological agents.
Dermatology in practice 2005; 13(1): 24–26
To continue reading this article, please sign in or register.